Scripintelligence - Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials

Scrip Clinica RAJ Scrip Clinical Research AnimalPharm

Advanced Search

Research & Development

Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials
September 2010

Authors : Louis Monnier , Claude Colette

Affliation : University of Montpellier I, Institute of Clinical Research, 641 Avenue du Doyen Giraud, 34093 Montpellier Cedex 5, France ; ; louis.monnier@inserm.fr

DOI : 10.1517/14656566.0.0.344415

Published in : Expert Opin. Pharmacother.

Subject: Review

Keywords: basal and prandial insulin regimens , Type 2 diabetes

Abstract

Background: Two studies, the Apollo...

Please Login to read the full article.

RELATED CONTENT

NEWS Scrip News

Other Informa News

ANALYSIS Scrip Analysis

Other Informa Analysis

COMMENT Scrip Comment

GLP-1 receptor agonists vie for diabetes market share

Other Informa Comment

Predicting the menopause

FEATURES Scrip Features

Other Informa Features

EVENTS

Cell Therapy Manufacturing

01 January 1970

London, UK

21st Annual Antibody Engineering Conference

01 January 1970

San Diego, US

Introduction to Biopharmaceutical Manufacturing

01 January 1970

Providence, Rhode Island, and San Francisco, California

JOB OF THE WEEK Promote your vacancy here

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Therapy Sector

Generics

Business

Policy & Regulation

Research & Development

International

Terms & Conditions

Scrip Clinical Research

Animal Pharm